• Measure Summary
  • NQMC:000333
  • 2002 Oct

Advanced chronic kidney disease (CKD): percent of patients treated with an erythropoietin or analogue.

Renal Physicians Association

  • Measure Summary
  • NQMC:009243
  • 2015 Jul

Proportion of days covered (PDC): percentage of patients who filled at least two prescriptions for a sulfonylurea or sulfonylurea combination on two unique dates of service who met the PDC threshold of 80% during the measurement period.

Pharmacy Quality Alliance

  • Measure Summary
  • NQMC:010540
  • 2015 Oct

Adherence to antipsychotic medications for individuals with schizophrenia: percentage of members 19 to 64 years of age during the measurement year with schizophrenia who were dispensed and remained on an antipsychotic medication for at least 80 percent of their treatment period.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:010177
  • 2015 Jan
  • NQF-Endorsed Measure

Statin use in persons with diabetes: percentage of patients ages 40 to 75 years who were dispensed a medication for diabetes that receive a statin medication.

Pharmacy Quality Alliance

  • Measure Summary
  • NQMC:009961
  • 2014 Nov

Potentially harmful drug-disease interactions in the elderly: percentage of Medicare patients 65 years of age and older who have evidence of an underlying disease, condition or health concern and who were dispensed an ambulatory prescription for a potentially harmful medication, concurrent with or after the diagnosis.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:010528
  • 2015 Oct

Statin therapy for patients with diabetes: percentage of members 40 to 75 years of age during the measurement year with diabetes who do not have ASCVD who remained on a statin medication of any intensity for at least 80% of the treatment period.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:009257
  • 2015 Jul

Drug-drug interactions: percentage of patients who received a prescription for a target medication during the measurement period and who were dispensed a concurrent prescription for a precipitant medication.

Pharmacy Quality Alliance

  • Measure Summary
  • NQMC:000342
  • 2002 Oct

Advanced chronic kidney disease (CKD): percent of patients with phosphorus greater than 4.5 mg/dL after a low phosphorus diet for one month, now on a phosphate binder.

Renal Physicians Association

  • Measure Summary
  • NQMC:009944
  • 2014 Nov
  • NQF-Endorsed Measure

Comprehensive adult diabetes care: percentage of patients 18 to 75 years of age with type 1 or type 2 diabetes who had an eye exam (retinal) performed.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:005026
  • 2009 Feb

Standardized methods for labeling, packaging and storing medications: percentage of failures in labeling of medications prepared in hospital pharmacy service.

Grupo de Investigación sobre Gestión de la Calidad en Servicios de Salud, University of Murcia, under contract to the Spanish Ministry of Health

  • Measure Summary
  • NQMC:010773
  • 2016 Jan

Proportion of days covered (PDC): percentage of patients with COPD who filled at least two prescriptions for any long-acting inhaled bronchodilator on two unique dates of service who met the PDC threshold of 80% during the measurement period.

Pharmacy Quality Alliance

  • Measure Summary
  • NQMC:009240
  • 2015 Jul

Proportion of days covered (PDC): percentage of patients who filled at least two prescriptions for a calcium channel blocker (CCB) or CCB combination on two unique dates of service who met the PDC threshold of 80% during the measurement period.

Pharmacy Quality Alliance

  • Measure Summary
  • NQMC:009260
  • 2015 Jul
  • NQF-Endorsed Measure

Antipsychotic use in persons with dementia: percentage of individuals 65 years and older with dementia who are receiving an antipsychotic medication without evidence of a psychotic disorder or related condition.

Pharmacy Quality Alliance

  • Measure Summary
  • NQMC:010542
  • 2015 Oct
  • NQF-Endorsed Measure

Annual monitoring for patients on persistent medications: percentage of members 18 years of age and older who received at least 180 treatment days of ambulatory medication therapy for a select therapeutic agent during the measurement year and at least one therapeutic monitoring event for the therapeutic agent in the measurement year.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:010525
  • 2015 Oct
  • NQF-Endorsed Measure

Comprehensive diabetes care: percentage of members 18 to 75 years of age with diabetes (type 1 and type 2) who received medical attention for nephropathy.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:009947
  • 2014 Nov
  • NQF-Endorsed Measure

Comprehensive adult diabetes care: percentage of patients 18 to 75 years of age with type 1 or type 2 diabetes who had a foot exam (visual inspection, a sensory exam with monofilament and a pulse exam) during the measurement year.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:009249
  • 2015 Jul

Diabetes medication dosing (DOS): percentage of patients who were dispensed a dose higher than the daily recommended dose for biguanides.

Pharmacy Quality Alliance

  • Measure Summary
  • NQMC:010517
  • 2015 Oct
  • NQF-Endorsed Measure

Persistence of beta-blocker treatment after a heart attack: percentage of members 18 years of age and older during the measurement year who were hospitalized and discharged from July 1 of the year prior to the measurement year to June 30 of the measurement year with a diagnosis of AMI and who received persistent beta-blocker treatment for six months after discharge.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:010511
  • 2015 Oct

Pharmacotherapy management of COPD exacerbation: percentage of COPD exacerbations for members 40 years of age and older who had an acute inpatient discharge or ED visit on or between January 1 and November 30 of the measurement year and who were dispensed a systemic corticosteroid within 14 days of the event.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:010550
  • 2015 Oct

Potentially harmful drug-disease interactions in the elderly: percentage of Medicare members 65 years of age and older who have evidence of an underlying disease, condition or health concern and who were dispensed an ambulatory prescription for a potentially harmful medication, concurrent with or after the diagnosis.

National Committee for Quality Assurance